Does Age Have a Differential Effect on 1 Month Versus 3 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients at High Bleeding Risk?

Am J Cardiol. 2024 Mar 15:215:96-97. doi: 10.1016/j.amjcard.2024.01.019. Epub 2024 Feb 1.

Authors

Ahmed Elkaryoni¹, Aakash Garg², J Dawn Abbott³

Affiliations

¹ Division of Cardiovascular Disease, Warren Alpert Medical School of Brown University, Lifespan Cardiovascular Institute, Providence, Rhode Island.
² Division of Cardiology, Ellis Hospital, Schenectady, New York.
³ Division of Cardiovascular Disease, Warren Alpert Medical School of Brown University, Lifespan Cardiovascular Institute, Providence, Rhode Island. Electronic address: jabbott@lifespan.org.

PMID: 38307175
DOI: 10.1016/j.amjcard.2024.01.019

No abstract available

Publication types

Editorial
Comment

MeSH terms

Health Services
Humans
Infant
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors* / therapeutic use

Substances

Platelet Aggregation Inhibitors